APA (7th ed.) Citation

M, V., JPN, P., M, L., MJ, L., J, F., W, M., . . . VG, C. (2024). Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma. Journal of medicinal chemistry, 67(2), 1447. https://doi.org/10.1021/acs.jmedchem.3c02002

Chicago Style (17th ed.) Citation

M, Visser, et al. "Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma." Journal of Medicinal Chemistry 67, no. 2 (2024): 1447. https://doi.org/10.1021/acs.jmedchem.3c02002.

MLA (9th ed.) Citation

M, Visser, et al. "Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma." Journal of Medicinal Chemistry, vol. 67, no. 2, 2024, p. 1447, https://doi.org/10.1021/acs.jmedchem.3c02002.